by Bill Pursche, McKinsey & Company, Inc.
The pharmaceutical industry is now in its second wave of consolidation. The first wave took place in the late 1980s,...
Creating Value from Horizontal Integration
The pharmaceutical industry is consolidating. Unaffordable overhead, redundant product lines, and excess sales and development capacity are creating the rationale for the new horizontal integration.
More from Business Strategy
More from In Vivo
• By
Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.
• By
J&J's EMEA head of digital solutions, Julia Fishman, talks about the hurdles in scaling digital innovation and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.
• By
Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success.